Figura suplementaria S3 de La terapia endocrina sinergiza con miméticos de SMAC para potenciar la presentación de antígenos y la regresión tumoral en cáncer de mama con receptor hormonal positivo

Hermida‐Prado et al. (Mon,) estudiaron esta cuestión.

www.synapsesocial.com/papers/68e586c1b6db6435875234af — DOI: https://doi.org/10.1158/0008-5472.27028624.v1

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Fig. S3 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
2. Supplementary Fig. S2 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
3. Supplementary Fig. S2 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
4. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
5. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024